Search results: Sage Journals

Restricted accessResearch articleFirst published June, 2019

Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency

Dennis P. Han, Christine Skumatz, Joseph C. Besharse [...]

Journal of Ocular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published September, 2019

Intravitreal Injections Among Medicare Part B Beneficiaries,2012-2016

Dallin J. Andersen, Parker E. Ludwig,BM, Adam C. Janot

Journal of VitreoRetinal Diseases

Restricted accessCase reportFirst published March, 2018

Anti-vascular endothelial growth factor for unilateral acute idiopathic maculopathy

Georgios Mylonas, Franz Prager, Barbara Wetzel [...]

European Journal of Ophthalmology

Restricted accessCase reportFirst published July, 2020

Prompt Improvement of an Enlarging Pigment Epithelial Detachment Following Intravitreal Dexamethasone in Neovascular Age-Related Macular Degeneration

James H. Powers, C. Ellis Wisely, Ananth Sastry [...]

Journal of VitreoRetinal Diseases

Free accessReview articleFirst published July, 2012

Aflibercept in wet age-related macular degeneration: a perspective review

Matthew Ohr, Peter K. Kaiser

Sage Open Chronic Disease

Restricted accessResearch articleFirst published October, 2023

Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval

Khemraj Hirani, Mylarrao Bansinath, Rahul Mittal [...]

Journal of Ocular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published May, 2021

Intravitreal aflibercept for management of choroidal neovascularization secondary to angioid streaks

Maurizio Battaglia Parodi, Maria Vittoria Cicinelli, Alessandro Marchese [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published November, 2023

Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME

Pasquale Viggiano, Maria Oliva Grassi, Giulia Bisceglia [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published September, 2016

Response to Bevacizumab after Treatment with Aflibercept in Eyes with Neovascular AMD

Maria Waizel, Annekatrin Rickmann, Björn R. Blanke [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published July, 2021

Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting

Marko Lukic, Maria Eleftheriadou, Robin D Hamilton [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published June, 2019

Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency

Dennis P. Han, Christine Skumatz, Joseph C. Besharse [...]

Journal of Ocular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published September, 2019

Intravitreal Injections Among Medicare Part B Beneficiaries,2012-2016

Dallin J. Andersen, Parker E. Ludwig,BM, Adam C. Janot

Journal of VitreoRetinal Diseases

Restricted accessCase reportFirst published March, 2018

Anti-vascular endothelial growth factor for unilateral acute idiopathic maculopathy

Georgios Mylonas, Franz Prager, Barbara Wetzel [...]

European Journal of Ophthalmology

Restricted accessCase reportFirst published July, 2020

Prompt Improvement of an Enlarging Pigment Epithelial Detachment Following Intravitreal Dexamethasone in Neovascular Age-Related Macular Degeneration

James H. Powers, C. Ellis Wisely, Ananth Sastry [...]

Journal of VitreoRetinal Diseases

Free accessReview articleFirst published July, 2012

Aflibercept in wet age-related macular degeneration: a perspective review

Matthew Ohr, Peter K. Kaiser

Sage Open Chronic Disease

Restricted accessResearch articleFirst published October, 2023

Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval

Khemraj Hirani, Mylarrao Bansinath, Rahul Mittal [...]

Journal of Ocular Pharmacology and Therapeutics

Restricted accessResearch articleFirst published May, 2021

Intravitreal aflibercept for management of choroidal neovascularization secondary to angioid streaks

Maurizio Battaglia Parodi, Maria Vittoria Cicinelli, Alessandro Marchese [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published November, 2023

Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME

Pasquale Viggiano, Maria Oliva Grassi, Giulia Bisceglia [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published September, 2016

Response to Bevacizumab after Treatment with Aflibercept in Eyes with Neovascular AMD

Maria Waizel, Annekatrin Rickmann, Björn R. Blanke [...]

European Journal of Ophthalmology

Restricted accessResearch articleFirst published July, 2021

Four-year outcomes of aflibercept treatment for neovascular age-related macular degeneration: Results from real-life setting

Marko Lukic, Maria Eleftheriadou, Robin D Hamilton [...]

European Journal of Ophthalmology